BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 29796724)

  • 1. The clinical importance of medulloblastoma extent of resection: a systematic review.
    Thompson EM; Bramall A; Herndon JE; Taylor MD; Ramaswamy V
    J Neurooncol; 2018 Sep; 139(3):523-539. PubMed ID: 29796724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis.
    Thompson EM; Hielscher T; Bouffet E; Remke M; Luu B; Gururangan S; McLendon RE; Bigner DD; Lipp ES; Perreault S; Cho YJ; Grant G; Kim SK; Lee JY; Rao AAN; Giannini C; Li KKW; Ng HK; Yao Y; Kumabe T; Tominaga T; Grajkowska WA; Perek-Polnik M; Low DCY; Seow WT; Chang KTE; Mora J; Pollack IF; Hamilton RL; Leary S; Moore AS; Ingram WJ; Hallahan AR; Jouvet A; Fèvre-Montange M; Vasiljevic A; Faure-Conter C; Shofuda T; Kagawa N; Hashimoto N; Jabado N; Weil AG; Gayden T; Wataya T; Shalaby T; Grotzer M; Zitterbart K; Sterba J; Kren L; Hortobágyi T; Klekner A; László B; Pócza T; Hauser P; Schüller U; Jung S; Jang WY; French PJ; Kros JM; van Veelen MC; Massimi L; Leonard JR; Rubin JB; Vibhakar R; Chambless LB; Cooper MK; Thompson RC; Faria CC; Carvalho A; Nunes S; Pimentel J; Fan X; Muraszko KM; López-Aguilar E; Lyden D; Garzia L; Shih DJH; Kijima N; Schneider C; Adamski J; Northcott PA; Kool M; Jones DTW; Chan JA; Nikolic A; Garre ML; Van Meir EG; Osuka S; Olson JJ; Jahangiri A; Castro BA; Gupta N; Weiss WA; Moxon-Emre I; Mabbott DJ; Lassaletta A; Hawkins CE; Tabori U; Drake J; Kulkarni A; Dirks P; Rutka JT; Korshunov A; Pfister SM; Packer RJ; Ramaswamy V; Taylor MD
    Lancet Oncol; 2016 Apr; 17(4):484-495. PubMed ID: 26976201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgery for recurrent medulloblastoma: A review.
    Rolland A; Aquilina K
    Neurochirurgie; 2021 Feb; 67(1):69-75. PubMed ID: 31351079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of neurosurgical advances and nuances in medulloblastoma therapy.
    Rechberger JS; Power EA; DeCuypere M; Daniels DJ
    Childs Nerv Syst; 2024 Apr; 40(4):1031-1044. PubMed ID: 38112693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article.
    Bloch O; Han SJ; Cha S; Sun MZ; Aghi MK; McDermott MW; Berger MS; Parsa AT
    J Neurosurg; 2012 Dec; 117(6):1032-8. PubMed ID: 23039151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Counseling Patients with a Glioblastoma Amenable Only for Subtotal Resection: Results of a Multicenter Retrospective Assessment of Survival and Neurologic Outcome.
    Coburger J; Segovia J; Ganslandt O; Ringel F; Wirtz CR; Renovanz M
    World Neurosurg; 2018 Jun; 114():e1180-e1185. PubMed ID: 29621607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proposed therapeutic strategy for adult low-grade glioma based on aggressive tumor resection.
    Nitta M; Muragaki Y; Maruyama T; Ikuta S; Komori T; Maebayashi K; Iseki H; Tamura M; Saito T; Okamoto S; Chernov M; Hayashi M; Okada Y
    Neurosurg Focus; 2015 Jan; 38(1):E7. PubMed ID: 25599276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma.
    Grabowski MM; Recinos PF; Nowacki AS; Schroeder JL; Angelov L; Barnett GH; Vogelbaum MA
    J Neurosurg; 2014 Nov; 121(5):1115-23. PubMed ID: 25192475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of postoperative complications and functional outcomes in pediatric patients with surgically treated fourth ventricle tumors.
    Haratek K; Bubeníková A; Entenmann CJ; Tomášek M; Zápotocký M; Sumerauer D; Kynčl M; Koblížek M; Libý P; Tichý M; Bradáč O; Beneš V
    Acta Neurochir (Wien); 2023 Dec; 165(12):4279-4292. PubMed ID: 37535206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Application of Sodium Fluorescein in Resection of Medulloblastoma Under YELLOW 560 Filter: Feasibility and Preliminary Results of a Monocentric Cohort and Systematic Review.
    Falco J; Broggi M; Rubiu E; Schiariti M; Restelli F; Mazzapicchi E; La Corte E; Ferroli P; Acerbi F
    World Neurosurg; 2024 Mar; 183():e386-e394. PubMed ID: 38154682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of medulloblastoma with postoperative chemotherapy alone: an SFOP prospective trial in young children.
    Grill J; Sainte-Rose C; Jouvet A; Gentet JC; Lejars O; Frappaz D; Doz F; Rialland X; Pichon F; Bertozzi AI; Chastagner P; Couanet D; Habrand JL; Raquin MA; Le Deley MC; Kalifa C;
    Lancet Oncol; 2005 Aug; 6(8):573-80. PubMed ID: 16054568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical outcome of children with medulloblastoma: a retrospective study of a 405-patient series from Children's Cancer Hospital Egypt (CCHE-57357).
    Enayet AE; Nabil M; Rady MR; Yousef Y; Badawy E; El Beltagy MA
    Childs Nerv Syst; 2021 Jun; 37(6):1931-1940. PubMed ID: 33604717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebellar medulloblastomas in adults.
    Ildan F; Cetinalp E; Bağdatoğlu H; Boyar B; Haciyakupoğlu S; Karadayi A
    Neurosurg Rev; 1994; 17(3):205-9. PubMed ID: 7838399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Which Parameter Is More Important for the Prognosis of New-Onset Adult Glioblastoma: Residual Tumor Volume or Extent of Resection?
    Xing Y; Wang X
    World Neurosurg; 2018 Aug; 116():e444-e451. PubMed ID: 29753893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extent of resection in patients with glioblastoma: limiting factors, perception of resectability, and effect on survival.
    Orringer D; Lau D; Khatri S; Zamora-Berridi GJ; Zhang K; Wu C; Chaudhary N; Sagher O
    J Neurosurg; 2012 Nov; 117(5):851-9. PubMed ID: 22978537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult medulloblastoma: an analysis of survival and prognostic factors.
    Le QT; Weil MD; Wara WM; Lamborn KR; Prados MD; Edwards MS; Gutin PH
    Cancer J Sci Am; 1997; 3(4):238-45. PubMed ID: 9263630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glioblastoma surgery with and without intraoperative MRI at 3.0T.
    Napolitano M; Vaz G; Lawson TM; Docquier MA; van Maanen A; Duprez T; Raftopoulos C
    Neurochirurgie; 2014 Aug; 60(4):143-50. PubMed ID: 24975207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When gross total resection of a glioblastoma is possible, how much resection should be achieved?
    Chaichana KL; Cabrera-Aldana EE; Jusue-Torres I; Wijesekera O; Olivi A; Rahman M; Quinones-Hinojosa A
    World Neurosurg; 2014; 82(1-2):e257-65. PubMed ID: 24508595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medulloblastoma with epithelioid features in the cerebellar vermis.
    Miyata K; Hori T; Yamakawa K; Takasu M; Hayakawa T; Shimomura Y; Iwata A; Okumura A; Nakura T; Jyoko M; Mori Y; Takahashi E; Hirato J
    Pediatr Int; 2016 Sep; 58(9):908-12. PubMed ID: 27452626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Volumetric Analysis Using Low-Field Intraoperative Magnetic Resonance Imaging for 168 Newly Diagnosed Supratentorial Glioblastomas: Effects of Extent of Resection and Residual Tumor Volume on Survival and Recurrence.
    Fukui A; Muragaki Y; Saito T; Maruyama T; Nitta M; Ikuta S; Kawamata T
    World Neurosurg; 2017 Feb; 98():73-80. PubMed ID: 27989974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.